The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
NGS-Global Market Insights and Sales Trends 2025
Synopsis
The massively parallel sequencing technology known as next-generation sequencing (NGS) has revolutionized the biological sciences. With its ultra-high throughput, scalability, and speed, NGS enables researchers to perform a wide variety of applications and study biological systems at a level never before possible.
The global NGS market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of NGS in various end use industries. The expanding demands from the Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Others, are propelling NGS market. NovaSeq, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the NextSeq segment is estimated at % CAGR for the next seven-year period.
Today's complex genomic research questions demand a depth of information beyond the capacity of traditional DNA sequencing technologies. Next-generation sequencing has filled that gap and become an everyday research tool to address these questions.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for NGS, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global NGS market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global NGS market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, NGS sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of NGS covered in this report include Illumina (US), Thermo Fisher Scientific (US), Pacific Biosciences of California (US), BGI (China), PerkinElmer (US), Agilent Technologies (US), QIAGEN(Germany), Macrogen(South Korea) and Oxford Nanopore Technologies, Ltd. (UK), etc.
The global NGS market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina (US)
Thermo Fisher Scientific (US)
Pacific Biosciences of California (US)
BGI (China)
PerkinElmer (US)
Agilent Technologies (US)
QIAGEN(Germany)
Macrogen(South Korea)
Oxford Nanopore Technologies, Ltd. (UK)
Eurofins Scientific (Luxembourg)
Global NGS market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global NGS market, Segment by Type:
NovaSeq
NextSeq
Sequel
Nanopore
Global NGS market, by Application
Academic Institutes & Research Centers
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of NGS companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The massively parallel sequencing technology known as next-generation sequencing (NGS) has revolutionized the biological sciences. With its ultra-high throughput, scalability, and speed, NGS enables researchers to perform a wide variety of applications and study biological systems at a level never before possible.
The global NGS market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of NGS in various end use industries. The expanding demands from the Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Others, are propelling NGS market. NovaSeq, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the NextSeq segment is estimated at % CAGR for the next seven-year period.
Today's complex genomic research questions demand a depth of information beyond the capacity of traditional DNA sequencing technologies. Next-generation sequencing has filled that gap and become an everyday research tool to address these questions.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for NGS, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global NGS market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global NGS market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, NGS sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of NGS covered in this report include Illumina (US), Thermo Fisher Scientific (US), Pacific Biosciences of California (US), BGI (China), PerkinElmer (US), Agilent Technologies (US), QIAGEN(Germany), Macrogen(South Korea) and Oxford Nanopore Technologies, Ltd. (UK), etc.
The global NGS market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina (US)
Thermo Fisher Scientific (US)
Pacific Biosciences of California (US)
BGI (China)
PerkinElmer (US)
Agilent Technologies (US)
QIAGEN(Germany)
Macrogen(South Korea)
Oxford Nanopore Technologies, Ltd. (UK)
Eurofins Scientific (Luxembourg)
Global NGS market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global NGS market, Segment by Type:
NovaSeq
NextSeq
Sequel
Nanopore
Global NGS market, by Application
Academic Institutes & Research Centers
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of NGS companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of NGS
1.1 NGS Market Overview
1.1.1 NGS Product Scope
1.1.2 NGS Market Status and Outlook
1.2 Global NGS Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global NGS Market Size by Region (2018-2029)
1.4 Global NGS Historic Market Size by Region (2018-2023)
1.5 Global NGS Market Size Forecast by Region (2024-2029)
1.6 Key Regions, NGS Market Size (2018-2029)
1.6.1 North America NGS Market Size (2018-2029)
1.6.2 Europe NGS Market Size (2018-2029)
1.6.3 Asia-Pacific NGS Market Size (2018-2029)
1.6.4 Latin America NGS Market Size (2018-2029)
1.6.5 Middle East & Africa NGS Market Size (2018-2029)
2 NGS Market by Type
2.1 Introduction
2.1.1 NovaSeq
2.1.2 NextSeq
2.1.3 Sequel
2.1.4 Nanopore
2.2 Global NGS Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global NGS Historic Market Size by Type (2018-2023)
2.2.2 Global NGS Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America NGS Revenue Breakdown by Type (2018-2029)
2.3.2 Europe NGS Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific NGS Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America NGS Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa NGS Revenue Breakdown by Type (2018-2029)
3 NGS Market Overview by Application
3.1 Introduction
3.1.1 Academic Institutes & Research Centers
3.1.2 Hospitals & Clinics
3.1.3 Pharmaceutical & Biotechnology Companies
3.1.4 Others
3.2 Global NGS Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global NGS Historic Market Size by Application (2018-2023)
3.2.2 Global NGS Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America NGS Revenue Breakdown by Application (2018-2029)
3.3.2 Europe NGS Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific NGS Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America NGS Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa NGS Revenue Breakdown by Application (2018-2029)
4 NGS Competition Analysis by Players
4.1 Global NGS Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in NGS as of 2022)
4.3 Date of Key Players Enter into NGS Market
4.4 Global Top Players NGS Headquarters and Area Served
4.5 Key Players NGS Product Solution and Service
4.6 Competitive Status
4.6.1 NGS Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Illumina (US)
5.1.1 Illumina (US) Profile
5.1.2 Illumina (US) Main Business
5.1.3 Illumina (US) NGS Products, Services and Solutions
5.1.4 Illumina (US) NGS Revenue (US$ Million) & (2018-2023)
5.1.5 Illumina (US) Recent Developments
5.2 Thermo Fisher Scientific (US)
5.2.1 Thermo Fisher Scientific (US) Profile
5.2.2 Thermo Fisher Scientific (US) Main Business
5.2.3 Thermo Fisher Scientific (US) NGS Products, Services and Solutions
5.2.4 Thermo Fisher Scientific (US) NGS Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific (US) Recent Developments
5.3 Pacific Biosciences of California (US)
5.3.1 Pacific Biosciences of California (US) Profile
5.3.2 Pacific Biosciences of California (US) Main Business
5.3.3 Pacific Biosciences of California (US) NGS Products, Services and Solutions
5.3.4 Pacific Biosciences of California (US) NGS Revenue (US$ Million) & (2018-2023)
5.3.5 BGI (China) Recent Developments
5.4 BGI (China)
5.4.1 BGI (China) Profile
5.4.2 BGI (China) Main Business
5.4.3 BGI (China) NGS Products, Services and Solutions
5.4.4 BGI (China) NGS Revenue (US$ Million) & (2018-2023)
5.4.5 BGI (China) Recent Developments
5.5 PerkinElmer (US)
5.5.1 PerkinElmer (US) Profile
5.5.2 PerkinElmer (US) Main Business
5.5.3 PerkinElmer (US) NGS Products, Services and Solutions
5.5.4 PerkinElmer (US) NGS Revenue (US$ Million) & (2018-2023)
5.5.5 PerkinElmer (US) Recent Developments
5.6 Agilent Technologies (US)
5.6.1 Agilent Technologies (US) Profile
5.6.2 Agilent Technologies (US) Main Business
5.6.3 Agilent Technologies (US) NGS Products, Services and Solutions
5.6.4 Agilent Technologies (US) NGS Revenue (US$ Million) & (2018-2023)
5.6.5 Agilent Technologies (US) Recent Developments
5.7 QIAGEN(Germany)
5.7.1 QIAGEN(Germany) Profile
5.7.2 QIAGEN(Germany) Main Business
5.7.3 QIAGEN(Germany) NGS Products, Services and Solutions
5.7.4 QIAGEN(Germany) NGS Revenue (US$ Million) & (2018-2023)
5.7.5 QIAGEN(Germany) Recent Developments
5.8 Macrogen(South Korea)
5.8.1 Macrogen(South Korea) Profile
5.8.2 Macrogen(South Korea) Main Business
5.8.3 Macrogen(South Korea) NGS Products, Services and Solutions
5.8.4 Macrogen(South Korea) NGS Revenue (US$ Million) & (2018-2023)
5.8.5 Macrogen(South Korea) Recent Developments
5.9 Oxford Nanopore Technologies, Ltd. (UK)
5.9.1 Oxford Nanopore Technologies, Ltd. (UK) Profile
5.9.2 Oxford Nanopore Technologies, Ltd. (UK) Main Business
5.9.3 Oxford Nanopore Technologies, Ltd. (UK) NGS Products, Services and Solutions
5.9.4 Oxford Nanopore Technologies, Ltd. (UK) NGS Revenue (US$ Million) & (2018-2023)
5.9.5 Oxford Nanopore Technologies, Ltd. (UK) Recent Developments
5.10 Eurofins Scientific (Luxembourg)
5.10.1 Eurofins Scientific (Luxembourg) Profile
5.10.2 Eurofins Scientific (Luxembourg) Main Business
5.10.3 Eurofins Scientific (Luxembourg) NGS Products, Services and Solutions
5.10.4 Eurofins Scientific (Luxembourg) NGS Revenue (US$ Million) & (2018-2023)
5.10.5 Eurofins Scientific (Luxembourg) Recent Developments
6 North America
6.1 North America NGS Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe NGS Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific NGS Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America NGS Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa NGS Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 NGS Market Dynamics
11.1 NGS Industry Trends
11.2 NGS Market Drivers
11.3 NGS Market Challenges
11.4 NGS Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
